These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 22647938)

  • 1. EpCAM and its potential role in tumor-initiating cells.
    Imrich S; Hachmeister M; Gires O
    Cell Adh Migr; 2012; 6(1):30-8. PubMed ID: 22647938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B; Cavard C; Perret C
    J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells.
    Chen Y; Yu D; Zhang H; He H; Zhang C; Zhao W; Shao RG
    Int J Biol Sci; 2012; 8(7):992-1004. PubMed ID: 22904667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.
    Yamashita T; Ji J; Budhu A; Forgues M; Yang W; Wang HY; Jia H; Ye Q; Qin LX; Wauthier E; Reid LM; Minato H; Honda M; Kaneko S; Tang ZY; Wang XW
    Gastroenterology; 2009 Mar; 136(3):1012-24. PubMed ID: 19150350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma.
    Yamashita T; Honda M; Nakamoto Y; Baba M; Nio K; Hara Y; Zeng SS; Hayashi T; Kondo M; Takatori H; Yamashita T; Mizukoshi E; Ikeda H; Zen Y; Takamura H; Wang XW; Kaneko S
    Hepatology; 2013 Apr; 57(4):1484-97. PubMed ID: 23174907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma.
    Ji J; Zheng X; Forgues M; Yamashita T; Wauthier EL; Reid LM; Wen X; Song Y; Wei JS; Khan J; Thorgeirsson SS; Wang XW
    Hepatology; 2015 Sep; 62(3):829-40. PubMed ID: 25953724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
    Karimi-Busheri F; Zadorozhny V; Li T; Lin H; Shawler DL; Fakhrai H
    J Stem Cells; 2011; 6(1):9-20. PubMed ID: 22997842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.
    Patriarca C; Macchi RM; Marschner AK; Mellstedt H
    Cancer Treat Rev; 2012 Feb; 38(1):68-75. PubMed ID: 21576002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.
    Ji J; Yamashita T; Budhu A; Forgues M; Jia HL; Li C; Deng C; Wauthier E; Reid LM; Ye QH; Qin LX; Yang W; Wang HY; Tang ZY; Croce CM; Wang XW
    Hepatology; 2009 Aug; 50(2):472-80. PubMed ID: 19585654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EpCAM expression in the prostate cancer makes the difference in the response to growth factors.
    Yoshida GJ; Saya H
    Biochem Biophys Res Commun; 2014 Jan; 443(1):239-45. PubMed ID: 24309103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.
    Wintzell M; Hjerpe E; Åvall Lundqvist E; Shoshan M
    BMC Cancer; 2012 Aug; 12():359. PubMed ID: 22901285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapy.
    Mitra M; Kandalam M; Harilal A; Verma RS; Krishnan UM; Swaminathan S; Krishnakumar S
    Mol Vis; 2012; 18():290-308. PubMed ID: 22328825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
    Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
    Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer.
    Subramanian N; Kanwar JR; Kanwar RK; Sreemanthula J; Biswas J; Khetan V; Krishnakumar S
    PLoS One; 2015; 10(7):e0132407. PubMed ID: 26176230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel function of EpCAM in oral squamous cell carcinoma cells under anchorage-independent conditions.
    Inoue H; Ohnishi Y; Nakajima M; Kakudo K; Nozaki M
    Int J Oncol; 2011 Dec; 39(6):1401-5. PubMed ID: 21785818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factors and molecular epigenetic marks underlying EpCAM overexpression in ovarian cancer.
    van der Gun BT; de Groote ML; Kazemier HG; Arendzen AJ; Terpstra P; Ruiters MH; McLaughlin PM; Rots MG
    Br J Cancer; 2011 Jul; 105(2):312-9. PubMed ID: 21694727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial cell adhesion molecule regulates tumor initiation and tumorigenesis via activating reprogramming factors and epithelial-mesenchymal transition gene expression in colon cancer.
    Lin CW; Liao MY; Lin WW; Wang YP; Lu TY; Wu HC
    J Biol Chem; 2012 Nov; 287(47):39449-59. PubMed ID: 22989882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and role of epithelial cell adhesion molecule in dysplastic nodule and hepatocellular carcinoma.
    Bae JS; Noh SJ; Jang KY; Park HS; Chung MJ; Park CK; Moon WS
    Int J Oncol; 2012 Dec; 41(6):2150-8. PubMed ID: 22993038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis.
    Spizzo G; Fong D; Wurm M; Ensinger C; Obrist P; Hofer C; Mazzoleni G; Gastl G; Went P
    J Clin Pathol; 2011 May; 64(5):415-20. PubMed ID: 21415054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells.
    Motohara T; Masuko S; Ishimoto T; Yae T; Onishi N; Muraguchi T; Hirao A; Matsuzaki Y; Tashiro H; Katabuchi H; Saya H; Nagano O
    Carcinogenesis; 2011 Nov; 32(11):1597-606. PubMed ID: 21828057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.